Christian Rolfo: Great editorial by Ticiana Batista and Suresh S. Ramalingam on 20 years of EGFR
Christian Rolfo, Associate Director Clinical Research Center of Thoracic Oncology at The Tisch Cancer Institute at Mount Sinai Health System and shared a post by ACS Journal Cancer on X/Twitter, adding:
”Great editorial by Ticiana Batista and Suresh S. Ramalingam on 20 years of EGFR. Very honored to have participate in NEJM publication of the first data of EGFR frequency and The Lancet Oncology EURTAC trial by my mentor and friend Rafael Rossell and Grupo Español de Cáncer de Pulmón colleagues. Big step for patients!”
Quoting ACS Journal Cancer’s post:
”Twenty years ago, the discovery of the EGFR mutation in lung cancer launched the era of personalized medicine in advanced NSCLC.
Read a new editorial from our Editorial Board Member Ticiana Batista and Editor-in-Chief Suresh S. Ramalingam.”
Source: Christian Rolfo/X and ACS Journal Cancer/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023